Revision arthroplasty after infection can often be complicated by both extensive bone loss and a relatively high rate of re-infection. Using allograft to address the bone loss in such patients is controversial because of the perceived risk of bacterial infection from the use of avascular graft material. We describe 12 two-stage revisions for infection in which segmental allografts were loaded with antibiotics using iontophoresis, a technique using an electrical potential to drive ionised antibiotics into cortical bone.
Revision arthroplasty after infection can often be complicated by both extensive bone loss and a relatively high rate of re-infection. Using allograft to address the bone loss in such patients is controversial because of the perceived risk of bacterial infection from the use of avascular graft material. We describe 12 two-stage revisions for infection in which segmental allografts were loaded with antibiotics using iontophoresis, a technique using an electrical potential to drive ionised antibiotics into cortical bone.
Iontophoresis produced high levels of antibiotic in the allograft, which eluted into the surrounding tissues. We postulate that this offers protection from infection in the high-risk peri-operative period. None of the 12 patients who had two-stage revision with iontophoresed allografts had further infection after a mean period of 47 months (14 to 78).
Many techniques have been used to treat infected arthroplasties including joint debridement, [1] [2] [3] resection arthroplasty, 4 arthrodesis 5, 6 and revision arthroplasty. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] All involve removal of the infected implant and thorough debridement of all necrotic tissue, foreign material and cement, often resulting in severely depleted bone stock. Bone deficiency after infection has traditionally been seen as a contraindication to the use of structural bone allograft, 8, 22 since the avascular allograft may be susceptible to re-infection. However, good results have been reported using morcellised allograft in two-stage revisions for infection in which impaction grafting is feasible. 23, 24 There are, however, few reports of the use of structural allograft in revision of infected arthroplasty. 14, 19, [25] [26] [27] [28] [29] [30] [31] [32] The advantage of using such allografts under these circumstances includes the opportunity to retain soft tissues and to use conventional revision prostheses. 26, 32 Megaprostheses can be used as an alternative, but bone loss may be so severe that it may be impossible to stabilise the new implant. 33 Furthermore, megaprostheses do not allow the biological re-attachment of tendons to bone, making any future surgery more difficult. 32, 33 Tumour prostheses are expensive, particularly if modular in design, 32 and have a rate of dislocation as high as 28% 34 in the hip, primarily due to violation of the abductor mechanism. 35 Because an allograft-prosthesis composite can heal to the host bone, the rotational stresses on the implant may be reduced once union has been established. 36 Graft-prosthesis composites have been reported to have better longterm survival and better function than megaprostheses. 34 Iontophoresis is a technique which employs an externally applied electric field to supplement allograft bone with antibiotics. [37] [38] [39] It has been described in disciplines ranging from dermatology to ophthalmology, 40 but its use in bone allograft is new. In the laboratory, iontophoresis has shown promising results, achieving levels of gentamicin of up to 187.1 mg/kg and of flucloxacillin of up to 31.9 mg/kg in sheep and in human allograft specimens. 41 Iontophoresed allografts have been shown to elute antibiotics for periods of up to two weeks, and these antibiotics have remained biologically active. This is a preliminary clinical report on the use of iontophoresis to supplement massive allografts with antibiotics in two-stage revision arthroplasty for infection.
Patients and Methods
Between December 1997 and July 2003, 12 patients undergoing two-stage revision for infection with major uncontained bony defects requiring structural allografts consented to receive iontophoresed grafts (Table I) . There were six men and six women with a mean age of 68 years (49 to 86). The operations were carried out by one of two experienced surgeons (including DJW) in laminar flow theatres using exhaust hoods.
Deep infections were due to Gram-positive organisms in seven patients and to a Gram-negative organism in one. In four, no organism was identified. However, two of these patients had draining sinuses and raised inflammatory markers, and two had abscesses with deep pus, one additionally presenting with erosive bone loss. In seven, the site of infection was an existing non-iontophoresed allograft (cases 2, 3, 4, 6, 7, 8 and 9) . In one (case 11), the site of the infection was an iontophoresed allograft initially implanted for nonunion of a peri-prosthetic fracture.
All but one of the patients underwent two-stage revision with a polymethylmethacrylate (PMMA) gentamicinloaded spacer for a mean period of 18 weeks (8 to 28) before the second-stage reconstruction. In one patient a Spacer-G (Zimmer, Warsaw, Indiana) was used, in three custom-made gentamicin-impregnated knee spacers and in seven custom-made hip spacers produced at the Royal Perth Hospital. In 11 patients more than one spacer was implanted over the course of their second stage. In one patient (case 4) second-stage reconstruction was undertaken 18 months after a Girdlestone resection procedure. The one Gram-negative bacillus isolated in this series was in a knee which became infected after a gunshot wound. This patient had an interval of six months between stages during which time he had a hospital-manufactured custommade knee spacer in situ .
The decision to proceed to the second stage was based on the patients' well-being and on their clinical picture, supported by the level of the erythrocyte sedimentation rate (ESR) and C-reactive protein in accordance with the recommendation of Ilyas and Morgan. 27 Antibiotic therapy was generally administered according to the Massachusetts General Hospital protocol, 42 but tailored to each patient's requirements with the assistance of a consultant in infectious diseases.
Of the 12 allografts implanted, nine were proximal femoral, two were distal femoral and one proximal tibial. All were obtained from our local tissue bank. They were harvested under sterile conditions, placed in 1 l of normal saline containing 1 g of cephalosporin and stored at -70˚C until cleared for further processing. Processed grafts were finally sterilised using 25 kGy of gamma irradiation before storage at -70˚C.
At operation, after removal from its packaging, the allograft was thawed in warm sterile water. Any remaining soft tissue was removed and the intramedullary canal was handreamed and cleaned by pulsatile lavage. One end of the bone was then occluded with bone cement and any nutrient foramina were sealed with bone wax. Once it had been demonstrated that the construct was watertight, the medullary cavity was filled with 4% gentamicin sulphate solution.
The allograft was suspended in the iontophoresis chamber containing 1% flucloxacillin sodium solution and a cylindrical mesh electrode was placed around the graft within the chamber. A Kirschner (K-) wire of appropriate length was placed centrally into the lumen and an electrical potential of 90 V was applied between the cathode (mesh) and the anode (K-wire) across the cortex of the bone (Fig. 1 ). Gentamicin carries a positive charge and flucloxacillin a negative charge in solution. These two antibiotics were selected because of their synergistic bactericidal activity against the organisms commonly encountered in allograft surgery. The allografts were iontophoresed for 20 minutes since this had been determined from laboratory studies to be the optimum time for iontophoresis. 37, 38 At 20 minutes, the flow of current, and therefore the movement of antibiotic ions in solution, reached a plateau after a period of peak activity. Therefore continuing the iontophoresis for longer than 20 minutes was of limited value since most of the antibiotic in solution had been deposited in the bone by this time. One patient with a penicillin allergy had his allograft iontophoresed using gentamicin only.
Once iontophoresis was complete, the allografts were prepared for implantation in the usual way. They were used with a wide array of prostheses including hinged knee prostheses, custom-made femoral and tibial stem extensions, acetabular cages and constrained acetabular liners. Antibioticloaded cement was employed in some instances but gentamicin-or flucloxacillin-loaded cement was avoided. Perioperative antibiotic prophylaxis was used, with intravenous antibiotics administered upon induction and in the early post-operative period, followed by oral therapy for up to six weeks (Table II) . At least one drain was placed alongside each allograft before closure of the wound. Samples of serum and fluid from the drain were taken at 2, 4, 8, 12, 24 and 48 hours post-operatively from seven patients from whom adequate samples were available and assayed for the concentration of antibiotic. Gentamicin was assayed using a competitive immunoassay on an ADVIA Centaur (Bayer Healthcare, Leverkusen, Germany). Flucloxacillin was assayed using high-performance liquid chromatography (Waters, Milford, Massachusetts).
Follow-up times were taken from the date of implantation of the iontophoresed allograft at the second stage of the revision. Clinical evaluations were performed pre-operatively and at 3, 6, and 12 months post-operatively, with annual review thereafter. The presence of post-operative allograft infection was determined on the basis of the clinical course, culture results and histology. Early deep postoperative infections were defined as those occurring within six months of surgery, according to the classification introduced by Coventry.
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Results
No patient was lost to clinical or radiological evaluation at a mean follow-up of 47 months (14 to 78; Table II ). Four patients died but their final review data were included in the study. One patient (case 6) whose primary surgery before infection had been the excision of a femoral chondrosarcoma, died from lung metastases 14 months after the second-stage procedure. Another (case 4) died from laryngeal cancer 56 months after the second stage, while the remaining two patients (cases 1 and 2) died from unrelated conditions aged 90 years (stroke) and 87 years (left ventricular failure secondary to ischaemic heart disease). None of the patients have become re-infected after implantation of their iontophoresed grafts at their latest follow-up, and all 12 allografts remain in situ , giving an allograft retention rate of 100%. fully treated by an abduction brace. One patient (case 12) had dislocation and loosening of a rotating hinged knee prosthesis requiring removal of the loose anti-rotational screw and plating of the femoral allograft to her native femoral shaft. The peg and tibial insert were also exchanged. Late complications. Nonunion in one patient (case 3) required bone grafting 26 months after operation. The patient subsequently developed a superficial infection which was successfully managed with antibiotics. The graft united to the host bone.
Antibiotic levels. The mean antibiotic levels at 2, 4, 8, 12, 24 and 48 hours assayed in the blood collected in the drains were above the minimum inhibitory concentration of Staphylococcus aureus for flucloxacillin (0.3 mg/l) and gentamicin (0.25 mg/l), while serum levels remained well below peak recommended serum levels for gentamicin (10 mg/l). The mean level of flucloxacillin in the drains was 17.67 mg/l at two hours (3.6 to 37, 3 patients) and 2.72 mg/l at 48 hours (1 to 6.2, 5 patients). Only one serum flucloxacillin assay was available at two hours with a level of 1 mg/l 
Discussion
Massive allografts have been used in musculoskeletal surgery for decades with varying reports of success. 8, 25, [28] [29] [30] [31] [32] 34, 42, Preservation of the soft-tissue envelope helps to stabilise the reconstruction 26, 32 and, in the hip, allows restoration of abductor function, providing a better functional outcome. 26 In the knee, it allows the use of an implant less constrained than a hinged prosthesis, resulting in decreased forces at the implant-allograft and allograft-host interfaces. 62 Reconstruction using allograft bone can result in loading of the host bone in a more physiological way 65 allowing a normal gradation of forces from the implant to the host bone. 61 The use of allograft in revision after sepsis represents a risk since it is avascular and therefore provides a favourable site for bacterial colonisation. 8 If infection recurs, it inevitably requires removal of the allograft, usually with resection arthroplasty as the definitive procedure. 14, 28, 29 There are few reports on the use of allograft bone in revision of a previously septic arthroplasty 14, 19, [25] [26] [27] [28] [29] [30] [31] [32] 68 and only one of these series has more than 12 patients 29 (Table III ). The reported rates of .re-infection vary and the relatively few patients per series make it difficult to determine the true rate of infection in this population. Berry et al 29 reported a rate of recurrence of 1 in 13 associated with massive allograft use, but the time to recurrence was not stated, while Loty et al 31 reported one early recurrence (before six months) in nine septic revisions. Nestor et al 14 used bulk femoral head allograft for structural support of porous prostheses in three septic revisions in a group of 34 patients and reported the recurrence of infection in one patient at 14 months. Ammon and Stockley 28 recently reported a recurrence of infection in two of 12 massive allografts used for infective revision. They used customised antibiotic cement beads but not systemic antibiotics to treat their patients before re-implantation. They did not specify whether the infections recurred early or late. Likewise, Graham and Stockley 32 recently reported a rate of recurrence of 1 in 5 after revision of septic total hip replacement using proximal femoral allografts, but did not specify the timing of the recurrence. Clatworthy et al 62 reported one recurrence of infection in six patients treated by two-stage revision and structural allograft after infection of a total knee replacement. Several authors have found no recurrence of infection when using massive allograft for septic revision [25] [26] [27] 30 but all in the series had fewer than 12 patients. As the use of allograft bone in revision after infection becomes widespread, larger series will become available, allowing a more accurate determination of the rate of recurrent infection to be made.
In 1999, Hanssen and Osmon 69 reported the incidence of peri-prosthetic infection caused by each bacterial species within their institution between 1969 and 1991. They found that the highest incidence for all micro-organisms occurred in the first three months post-operatively and then gradually decreased, levelling out at between 18 and 24 months after operation. They concluded that infections attributable to operative contamination or problems with wound-healing increased the incidence of infection in the early post-operative period. This was in agreement with the findings of several authors who noted that 75% of deep infections present within the first four months after operation. 42, 46, 49, 56 In view of this, allografts appear to be at highest risk of infection in the early post-operative period. The avascularity of the allograft makes it unlikely that antibiotics administered systemically will reach therapeutic levels within the graft. Allografts which are iontophoresed before implantation have the advantage of providing a local depot of antibiotics to the high-risk area, a concept which has been shown to be successful. 13, [70] [71] [72] [73] The high concentration of antibiotics in the graft itself could potentially safeguard it from infection. As these antibiotics diffuse out from the allograft, small crevices and holes in the bone, which ordinarily offer protection to bacteria, 74 are exposed to higher local concentrations of antibiotic than are delivered by systemic administration or from antibiotic-loaded cement. The current series and previous work, 41 including as yet unpublished data, have indicated that iontophoresis appears to be safe. The results for serum levels of gentamicin and flucloxacillin from 42 patients who have received iontophoresed allografts to date have indicated that they are well below recommended peak serum levels, while levels of both antibiotics assayed from the drains are well above the minimum inhibitory concentration of these antibiotics until removal of the drain at 48 hours. 39 The in vitro work 41 concerning iontophoresis has demonstrated that these allografts elute antibiotics over a period of at least two weeks. The application of iontophoresis to structural allografts in this series has resulted in no recurrence of infection in 12 previously infected arthroplasties. However, the 95% confidence limits for the true infection rate are 0% to 30%, given the small number of patients in this series. On this basis, it is impossible to make definite statements about the effectiveness of the technique, but the initial results are promising. To the authors' knowledge iontophoresis is the only way of loading massive cortical allografts with antibiotics before their implantation. It requires few additional resources in the operating theatre, given that preparation of the graft is carried out on a sterile trolley which would be used for this purpose regardless of the addition of iontophoresis, and this preparation can be carried out by an assistant whilst the main procedure is conducted, avoiding extra surgical time. The iontophoresis chamber is a simple polycarbonate cylinder requiring little space on the trolley, and the power supply requires only a small space on an unsterile surface. Once the graft is placed in the iontophoresis chamber it can be left unattended for the duration of iontophoresis. 33 in a review of the role of allografts in total hip replacement, stated that "The practice of restoring bone stock in revision arthroplasty of the hip is an accepted standard treatment for patients who are likely to face additional surgery during their lifetime, and it is imperative that technologies to facilitate the use of allograft tissue continue to be developed". The early results of our small series of antibiotic-supplemented cortical allografts are promising. Iontophoresis can be applied to massive grafts used to replace uncontained or circumferential defects or to grafts which are processed into struts. It is intended that iontophoresis of allograft bone should be used as an adjunct to antibiotic-loaded bone cement and systemic antibiotics in aiding prophylaxis of early recurrent infection. Further clinical data are required in order to evaluate the efficacy of this method.
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